1 / 6

Molecular Diagnostics Market to witness more than 8.4% CAGR from 2017 to 2024

Get more details @ http://bit.ly/2ePRhAo <br>Some of the players in global molecular diagnostics market are Abbott Molecular, BioMerieux’s, Cepheid, Danaher Corporation, Qiagen Gaithersburg, Roche diagnostics, and Siemens Healthcare.

jueekate
Download Presentation

Molecular Diagnostics Market to witness more than 8.4% CAGR from 2017 to 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Molecular Diagnostics Market Analysis, Growth, Share, Industry Trends and Analysis, Forecast to 2024:Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024

  2. Key Insights from Molecular Diagnostics Market : • Growing geriatric population base along with rising incidences of infectious diseases will act as high impact rendering factors for molecular diagnostics market. • Multifactorial benefits and applications of molecular diagnostics in therapeutic monitoring, detection of predisposition to disease, patient stratification, drug regimen selection and others will drive molecular diagnostics market growth. • Molecular Diagnostics Market size is set to exceed USD 12.5 billion by 2024; according to a new research report by Global Market Insights. • Increasing prevalence of infectious diseases in developing countries such as India coupled with growing demand for point of care diagnostic technologies (POCT) will fuel business growth. • Infectious disease segment held largest revenue share in 2016 and is expected to follow similar trend over the forecast timeframe due to increasing incidences of infectious diseases in developing countries of Asia Pacific and Latin America.

  3. Continued... • Sequencing is poised to be fastest growing technological segment during the forecast timeframe owing to advancement in next-generation sequencing technology and its application in cancer diagnosis and characterization. • U.S. molecular diagnostics market held largest revenue share in 2016 due to growing geriatric population, highly susceptible to suffer from various illnesses along with high technological adoption rate of U.S. • China molecular diagnostics market should grow at significant rate due to growing demand for advanced treatment coupled with rising prevalence of infectious diseases such as hepatitis in the country. • Some of the key industry players operating in global molecular diagnostics market are Abbott, Alere, Becton, Dickinson and Company, Biomerieux, Bio-Rad Laboratories, Danaher Corporation, GenMark Diagnostics, HTG Molecular Diagnostics, Johnson & Johnson, MDxHealth, Novartis (Grifols), Qiagen Gaithersburg, Siemens Healthcare and Roche.

  4. Germany Molecular Diagnostics Market, By Application, 2013 - 2024 (USD Million)

  5. Browse Full Market Research Report On Molecular Diagnostics Market @ http://bit.ly/2oUDIou Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/434

  6. Stay In Touch Website: www.gminsights.com Social Media:

More Related